Key Drivers
- Margin Compression
- Cash Resilience
- Rich Valuation
AIAI Summary
WAT now looks less like a steady defensive compounder and more like a cyclical inflection story, but with the stock already near resistance and valuation rich, the investment case hinges on whether broad-based organic growth can sustain and finally convert into margin leverage before the market starts pricing in disappointment.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Compression
- •Cash Resilience
- •Rich Valuation
WAT still shows strong full-year profitability and cash flow, but the latest quarter saw margin compression, an operating loss, and a demanding valuation that make the near-term outlook more cautious.
Price Behavior
Key Price Behavior Insights:
- •Breakout momentum
- •Near resistance
- •Support holding
Over the last month, WAT has been in a strong uptrend and could extend higher if it clears $415-$416, but a pullback is possible if it loses $400-$396.
Sharp rebound from $357.54 on 2026-07-20 made the move fast and extended
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Guidance Raise
- •Product Launch
Waters beat Q2 estimates with 9% organic constant-currency growth, raised full-year guidance, and reinforced improving momentum with a new clinical IVD launch and stronger investor interest.
The strong quarter, improved outlook, and product progress point to favorable near-term momentum for the stock
Similar Companies in Healthcare
Other companies in the same sector with AI ratings